271 related articles for article (PubMed ID: 9737569)
1. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study.
Ng IO; Shek TW; Nicholls J; Ma LT
J Gastroenterol Hepatol; 1998 Jan; 13(1):34-40. PubMed ID: 9737569
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Yano Y; Yamamoto J; Kosuge T; Sakamoto Y; Yamasaki S; Shimada K; Ojima H; Sakamoto M; Takayama T; Makuuchi M
Jpn J Clin Oncol; 2003 Jun; 33(6):283-7. PubMed ID: 12913082
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
Tang D; Nagano H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
J Gastrointest Surg; 2006; 10(7):987-98. PubMed ID: 16843869
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
6. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features.
Fukukura Y; Taguchi J; Nakashima O; Wada Y; Kojiro M
J Comput Assist Tomogr; 1997; 21(1):52-8. PubMed ID: 9022770
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
[TBL] [Abstract][Full Text] [Related]
9. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
Maeda T; Adachi E; Kajiyama K; Sugimachi K; Tsuneyoshi M
Hum Pathol; 1995 Sep; 26(9):956-64. PubMed ID: 7545644
[TBL] [Abstract][Full Text] [Related]
10. Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population.
Wang Y; Yang Q; Li S; Luo R; Mao S; Shen J
Clin Radiol; 2019 May; 74(5):407.e1-407.e10. PubMed ID: 30799097
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic features and diagnosis of mixed type hepatocellular carcinoma].
Lu J; Lin Z; Yuan S
Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):208-11. PubMed ID: 7656828
[TBL] [Abstract][Full Text] [Related]
13. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
14. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
15. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center.
Zhan Q; Shen BY; Deng XX; Zhu ZC; Chen H; Peng CH; Li HW
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):361-9. PubMed ID: 21744084
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
[TBL] [Abstract][Full Text] [Related]
19. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
[TBL] [Abstract][Full Text] [Related]
20. Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report.
Tanaka K; Honna T; Kitano Y; Kuroda T; Tanaka K; Morikawa N; Matsuda H; Kawashima N; Matsuoka K; Miyauchi J
J Clin Pathol; 2005 Aug; 58(8):884-7. PubMed ID: 16049296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
